Headquarters
4620 HENRY STREET, PITTSBURGH, PA 15213-3715, US
PITTSBURGH, PA, US
CAPTIS DIAGNOSTICS INC.
From the company
Captis Diagnostics develops extracellular vesicle (EV) isolation technology for minimally invasive human disease research and clinical diagnostics. Its Lipid Nanoprobe (LNP) platform enables rapid, high-efficiency EV isolation from human biofluids in 15 minutes or less without ultracentrifugation, supporting DNA mutation detection, RNA sequencing, and proteomics from a single blood draw. The company also offers precision EV isolation kits for multi-omics discovery and proteomics workflows.
Products & services offered
Capabilities 8
- DNA mutation detection
- epigenomic profiling
- extracellular vesicle isolation
- liquid biopsy
- magnetic separation
- next-generation sequencing
View all 8
Materials 4
Classifications
- Materials (4)
- lipid-PEGm-biotin, magnetic nanospheres, nanostructured silica, NeutrAvidin
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.